![Carlos Alberto Garrido Arribas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carlos Alberto Garrido Arribas
Director/Board Member at Palobiofarma SL
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Juan Camacho | M | - |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | 21 years |
Josep María Echarri Torres | M | 48 |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | 14 years |
María Eugenia Lecumberri Alli | F | 59 |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | - |
Jesús Javier Cía Barrio | M | - |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | - |
Don Santiago de Torres Sanahuja | M | - |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | - |
Lyhen González Lio | F | - |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | - |
Alely Gessa Abreu | F | - |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | - |
Nahomi Castro-Palomino Laria | F | - |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | - |
Jaume Busquets Viñallonga | M | - |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | - |
Julio Cesar Castro-Palomino | M | - |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Carlos Méndez Garrido | M | - |
FIT Inversión en Talento y Emprendimiento SGEIC SA
![]() FIT Inversión en Talento y Emprendimiento SGEIC SA Investment ManagersFinance FIT Inversión en Talento y Emprendimiento SGEIC SA (Fitalent) is the venture capital subsidiary of information technology and outsourcing firm Everis Spain SL. Established in 2011, the firm is based in Madrid and manages the Fitalent Fund, investing in early-stage technology companies aiming to transform them into profitable, market-leading businesses. Fitalent's reference investor and partner, everis, provides assistance with strategic and business issues, legal and administrative advice, technological expertise, commercial activity, marketing, access to business contacts and simplifying international expansion. | 6 years |
Moisés Menéndez Andrés | M | - |
FIT Inversión en Talento y Emprendimiento SGEIC SA
![]() FIT Inversión en Talento y Emprendimiento SGEIC SA Investment ManagersFinance FIT Inversión en Talento y Emprendimiento SGEIC SA (Fitalent) is the venture capital subsidiary of information technology and outsourcing firm Everis Spain SL. Established in 2011, the firm is based in Madrid and manages the Fitalent Fund, investing in early-stage technology companies aiming to transform them into profitable, market-leading businesses. Fitalent's reference investor and partner, everis, provides assistance with strategic and business issues, legal and administrative advice, technological expertise, commercial activity, marketing, access to business contacts and simplifying international expansion. | 6 years |
Statistics
Country | Connections | % of total |
---|---|---|
Spain | 12 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Carlos Alberto Garrido Arribas
- Personal Network